Pharmacokinetics

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson’s Research at Neuroscience 2018

Singapore, November 24, 2018: Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) (“SeD”), through its subsidiary, Global BioLife Inc. (“Global…

6 years ago

Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab

Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at…

6 years ago